Updates

2023

Market Street Announces Lighting Luminary for 16th Annual Christmas Tree Lighting (Hello Woodlands - October 30, 2023)

SQUID increases accessibility to single-cell tumor profiling to improve treatment outcomes (Baylor College of Medicine - August 22, 2023)

CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial (Baylor College of Medicine - May 15, 2023)

Former NFL Player Devon Still on his daughter’s cancer diagnosis, recovery (Fox & Friends - March 26, 2023)

2022

Pilot grants awarded to researchers for innovative therapies (Texas Children's Hospital - September 7, 2022)

Researchers identify an Achilles’ heel in neuroblastoma (Baylor College of Medicine - August 16, 2022)

2021

Turning the molecular clock back on halts neuroblastoma tumor growth (Baylor College of Medicine - July 27, 2021)

Restoring molecular clock suppresses neuroblastoma tumor growth (Baylor College of Medicine - June 28, 2021)

Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine present new clinical data on GD2 CAR-NKT cells in neuroblastoma at ASGCT Annual Meeting (Athenex - May 17, 2021)

2020

CAR NKT cells, a promising step forward in the treatment of solid tumors ( Baylor College of Medicine - November 10, 2020)

Understanding the cancer risk in children with birth defects (Baylor College of Medicine - June 25, 2020)

2019

Cancer Center on forefront of cutting-edge research, clinical trials (September 17, 2019 - Texas Children's Hospital)

Meet Eden: 2019 Family Advocacy Day Champion (Speak Now for Kids - May 18, 2019)

New experimental therapy CAR NKT-cells tested in cancer patients for the first time (Forbes - May 1, 2019)

Survivor doing what he can to help fight childhood cancer (KPRC 2 - March 12, 2019)

Venkatramani named director of Solid Tumor Programs (Texas Children's Hospital - January 7, 2019)

2018

September Superhero: Eden (KPRC 2 - September 20, 2018)

First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT) (Cell Medica - September 27, 2018)

First-in-human clinical trial aims to treat neuroblastoma (Baylor College of Medicine - June 15, 2018)

2017

Texas Children’s Hospital Opens MIBG Suite (Healthcare Design Magazine - December 5, 2017)

Alex’s Lemonade Stand funds Phase 1 neuroblastoma trial (Baylor College of Medicine - December 4, 2017)

Texas Children’s Cancer Center to host neuroblastoma research conference (Texas Children's Hospital - April 08, 2017)

New MIBG treatment room opens for patients with neuroblastoma (Texas Children's Hospital - February 06, 2017)

International Neuroblastoma Research Conference will be May 3-5, 2017 (Texas Children's Hospital - January 17, 2017)

2016

Shine a light on neuroblastoma  (TMC News - February 03, 2016)

2015

Neuroblastoma research at Baylor receives funding through support of Today show viewers (Texas Children's Hospital - December 18, 2015)

2013

Pediatric Oncologist Receives Grant for Neuroblastoma Research (Texas Children's Hospital - July 10, 2013)

Phase 1 trial uses enhanced T cells to treat neuroblastoma (Texas Children's Hospital - June 10, 2013)

2012

Texas Children’s Cancer Center researchers present at world-renowned ANR neuroblastoma conference (Texas Children's Hospital - June 18, 2012)

Study presents potential new treatment options for pediatric neuroblastoma patients (Texas Children's Hospital - April 27, 2012)

2011

Grants support efforts to improve neuroblastoma treatment (Texas Children's Hospital - October 19, 2011)

2009

New Clinical Trials newsletter highlights neuroblastoma research at Texas Children’s Cancer Center (Texas Children's Hospital - February 05, 2009)

Unlocking the key to treating Neuroblastoma tumors in children (Texas Children's Hospital - January 23, 2009)

2008

Researchers use double-barreled immune cell approach for neuroblastoma (Texas Children's Hospital - November 02, 2008)

Ranked #6 in Cancer

Proud to be ranked one of the best children’s cancer centers in the country by U.S. News & World Report for seven consecutive years.